Chen, Emmalyn

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

Esteva, A., Feng, J., van der Wal, D., Huang, S.-C., Simko, J. P., DeVries, S., Chen, E., Schaeffer, E. M., Morgan, T. M., Sun, Y., et al. (2022) · npj Digital Medicine

Radiomics and Machine Learning in Medical ImagingAI in cancer detection

Cited by 217

Artificial intelligence predictive model for hormone therapy use in prostate cancer

Spratt, D. E., Tang, S., Sun, Y., Huang, H.-C., Chen, E., Mohamad, O., Armstrong, A. J., Tward, J. D., Nguyen, P. L., Lang, J. M., et al. (2023) · NEJM Evidence

Prostate Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging

Cited by 153

External validation of a digital pathology-based multimodal artificial intelligence architecture in the NRG/RTOG 9902 phase 3 trial

Ross, A. E., Zhang, J., Huang, H.-C., Yamashita, R., Keim-Malpass, J., Simko, J. P., DeVries, S., Morgan, T. M., Souhami, L., Dobelbower, M. C., et al. (2024) · European Urology Oncology

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 35

Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer

Wang, J. H., Deek, M. P., Mendes, A. A., Song, Y., Shetty, A., Bazyar, S., Van der Eecken, K., Chen, E., Showalter, T. N., Royce, T. J., et al. (2025) · Radiotherapy and Oncology

Prostate Cancer Treatment and ResearchRadiomics and Machine Learning in Medical Imaging

Cited by 25